Active Ingredient(s): Rolapitant
FDA Approved: * September 1, 2015
Pharm Company: * TESARO INC
Category: Nausea & Vomiting

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Recent Varubi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Emulsion: 166.5mg/92.5ml (1.8mg/ml)
  • Injection: 166.5mg/92.5ml(1.8mg/ml)
  • Tablet: 90mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Varubi: (3 results)

Sorted by National Drug Code
  • 69656-101 Varubi 90 mg Oral Tablet by Tesaro, Inc.
  • 69656-102 Varubi 1.8 mg/ml Intravenous Injection, Emulsion by Tesaro, Inc.
  • 70720-101 Varubi 90 mg Oral Tablet by Tersera Therapeutics LLC

Other drugs which contain Rolapitant or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA